This is the authors' abstract. We don't add key points for this paper.
The history of multidisciplinary tumor boards extends to more than 50 years ago. At JADPRO Live Virtual 2021, presenters discussed the evidence-based impact of tumor boards on patient outcomes and patient-centered care, reviewed benefits and limitations of multidisciplinary tumor boards, and explained the potential role of advanced practitioners in tumor boards in a variety of oncology practice types.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Okasako et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: